Jeff Mathiesen

Biography

Jeff Mathiesen serves as Chief Financial Officer. Prior to joining Gemphire Therapeutics, he served as CFO of Sunshine Heart, Inc., leading the medical device company through its transition from the Australian capital markets to the U.S., which included a successful IPO and equity financings totaling approximately $100 million. Mr. Mathiesen has more than 20 years of experience as Chief Financial Officer (CFO) of publicly traded companies, including two successful initial public offerings (IPOs). His experience encompasses a variety of highly competitive, technology based industries in organizations with global reach and includes several M&A transactions, divestitures, organizational development and equity and debt financing. He began his career at Deloitte. Mr. Mathiesen also serves as Director and Audit Committee Chair of Sun BioPharma, Inc. a publicly traded biopharmaceutical company developing therapies for pancreatic diseases. Mr. Mathiesen graduated summa cum laude from the University of South Dakota with a B.S. degree in Accounting.

Research Interest

 Medical device,Biopharmaceutical,Business & Management